Figure 7

Hepatic expression of cannabinoid type 1 (CB1) and CB2 receptors. (a, b) Hepatic CB1 and CB2 receptor gene expression and (c, d) densitometric quantification (upper) plus representative images (lower) of western blot analysis of CB1 and CB2 receptor protein expression in healthy rats (CT), in pre-ascitic cirrhotic rats (CHBasal) and in rats receiving the vehicle (CHVehicle) or 10 mg/kg/day of the CB1-antagonist Rimonabant (CHRimonabant) for 2 additional weeks. Data are expressed as mean±s.e.